Baton Rouge, LA, United States of America

Fengtian Xue


Average Co-Inventor Count = 2.4

ph-index = 4

Forward Citations = 56(Granted Patents)


Location History:

  • Baton Rogue, LA (US) (2015)
  • Baton Rouge, LA (US) (2012 - 2017)

Company Filing History:


Years Active: 2012-2017

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Fengtian Xue: Innovator in Nitric Oxide Synthase Inhibitors

Introduction

Fengtian Xue is a prominent inventor based in Baton Rouge, LA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of nitric oxide synthase inhibitors. With a total of 11 patents to his name, Xue's work has the potential to impact the treatment of various neurodegenerative diseases.

Latest Patents

Among his latest patents are "Intramolecular hydrogen-bonded nitric oxide synthase inhibitors - Compounds and related compositions and methods as can be used to selectively inhibit neuronal nitric oxide synthase and as can be employed in the treatment of various neurodegenerative diseases." This patent focuses on innovative compounds that can selectively target neuronal nitric oxide synthase. Another notable patent is "Chiral synthesis of pyrrolidine core compounds en route to neuronal nitric oxide synthase inhibitors - A chiral synthesis of pyrrolidine compounds en route to selective neuronal nitric oxide synthase inhibitors, and representative inhibitor compounds heretofore unattainable." This work highlights his expertise in chiral synthesis and its application in drug development.

Career Highlights

Fengtian Xue has worked at prestigious institutions such as Northwestern University and the University of California. His research has been instrumental in advancing the understanding of nitric oxide synthase and its role in neurodegenerative diseases. His innovative approaches have garnered attention in the scientific community.

Collaborations

Xue has collaborated with notable colleagues, including Richard B Silverman and Frank L Meyskens. These partnerships have further enriched his research and contributed to the development of groundbreaking therapies.

Conclusion

Fengtian Xue's contributions to the field of nitric oxide synthase inhibitors demonstrate his commitment to advancing medical science. His innovative patents and collaborations reflect his significant impact on the treatment of neurodegenerative diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…